209 related articles for article (PubMed ID: 26751412)
41. Preliminary results of a new small-bore percutaneous pleural catheter used for treatment of malignant pleural effusions in ECOG PS 3-4 patients.
Filosso PL; Sandri A; Felletti G; Ruffini E; Lausi PO; Oliaro A
Eur J Surg Oncol; 2011 Dec; 37(12):1093-8. PubMed ID: 21963043
[TBL] [Abstract][Full Text] [Related]
42. Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.
Shojaee S; Singh I; Solsky I; Nana-Sinkam P
Respiration; 2019; 98(3):198-202. PubMed ID: 31121583
[TBL] [Abstract][Full Text] [Related]
43. Better effect of intrapleural perfusion with hyperthermic chemotherapy by video-assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity.
Cao Y; Zhang Q; Huang Z; Chai Z; Liu J; Wang J; Sun Z; Zhao T; Wang G; Chen G; Han Y; Li Q; Hong X
Cancer Med; 2022 Jan; 11(2):348-357. PubMed ID: 34854253
[TBL] [Abstract][Full Text] [Related]
44. Pleural Fluid Adenosine Deaminase (ADA) Predicts Survival in Patients with Malignant Pleural Effusion.
Terra RM; Antonangelo L; Mariani AW; de Oliveira RL; Teixeira LR; Pego-Fernandes PM
Lung; 2016 Aug; 194(4):681-6. PubMed ID: 27300446
[TBL] [Abstract][Full Text] [Related]
45. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.
Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE
Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918
[TBL] [Abstract][Full Text] [Related]
46. [Survival of malignant and paramalignant pleural effusions in Ouagadougou].
Bambara AT; Ouédraogo SM; Maïga S; Sondo KA; Boncoungou/Nikièma K; Ouédraogo G; Koumbem B; Ouédraogo AS; Djibril M; Badoum G; Ouédraogo AR; Ouédraogo M
Rev Pneumol Clin; 2016 Dec; 72(6):346-352. PubMed ID: 27776946
[TBL] [Abstract][Full Text] [Related]
47. [The thoracoscopic talc pleurodesis with intraoperative pleural biopsy - a retrospective analysis in patients with malignant pleural effusion].
Hoksch B; Seidel N; Beshay M; Schmid RA
Zentralbl Chir; 2010 Feb; 135(1):54-8. PubMed ID: 20029741
[TBL] [Abstract][Full Text] [Related]
48. Recent advances in the diagnosis and management of malignant pleural effusions.
Heffner JE; Klein JS
Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636
[TBL] [Abstract][Full Text] [Related]
49. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial.
Mohsen TA; Zeid AA; Meshref M; Tawfeek N; Redmond K; Ananiadou OG; Haj-Yahia S
Eur J Cardiothorac Surg; 2011 Aug; 40(2):282-6. PubMed ID: 20961772
[TBL] [Abstract][Full Text] [Related]
50. Diagnosis and management of malignant pleural effusions.
Heffner JE
Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
[TBL] [Abstract][Full Text] [Related]
51. [Value of thoracoscopy and talc pleurodesis in diagnosis and palliative treatment of malignant pleural mesothelioma].
Charvat JC; Brutsche M; Frey JG; Tschopp JM
Praxis (Bern 1994); 1998 Mar; 87(10):336-40. PubMed ID: 9545840
[TBL] [Abstract][Full Text] [Related]
52. The impact of tunneled pleural catheters on the quality of life of patients with malignant pleural effusions.
Sabur NF; Chee A; Stather DR; Maceachern P; Amjadi K; Hergott CA; Dumoulin E; Gonzalez AV; Tremblay A
Respiration; 2013; 85(1):36-42. PubMed ID: 23154202
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion.
Yang J; Zhu Y; Wu L; Zhu W; Zhang X; Yang Y; Xu C
Clin Respir J; 2018 Jan; 12(1):279-284. PubMed ID: 27402224
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
Shi XY; Yi FS; Wang Z; Qiao X; Zhai K
Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116
[TBL] [Abstract][Full Text] [Related]
55. Clinical predictors and outcomes of non-expandable lung following percutaneous catheter drainage in lung cancer patients with malignant pleural effusion.
Kim CH; Park JE; Cha JG; Park J; Choi SH; Seo H; Yoo SS; Lee SY; Cha SI; Park JY; Lim JK; Lee J
Medicine (Baltimore); 2023 Jun; 102(26):e34134. PubMed ID: 37390258
[TBL] [Abstract][Full Text] [Related]
56. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.
Akopov AL; Egorov VI; Varlamov VV; Levashev YN; Artioukh DY
Eur J Cardiothorac Surg; 2005 Nov; 28(5):750-3. PubMed ID: 16198593
[TBL] [Abstract][Full Text] [Related]
57. Malignant pleural effusion in the palliative care setting.
Arber A; Clackson C; Dargan S
Int J Palliat Nurs; 2013 Jul; 19(7):320, 322-5. PubMed ID: 24273808
[TBL] [Abstract][Full Text] [Related]
58. Video-assisted management of malignant pleural effusion in breast carcinoma.
Gasparri R; Leo F; Veronesi G; De Pas T; Colleoni M; Maisonneuve P; Pelosi G; Galimberti V; Spaggiari L
Cancer; 2006 Jan; 106(2):271-6. PubMed ID: 16342163
[TBL] [Abstract][Full Text] [Related]
59. A propensity-matched comparison of pleurodesis or tunneled pleural catheter in patients undergoing diagnostic thoracoscopy for malignancy.
Freeman RK; Ascioti AJ; Mahidhara RS
Ann Thorac Surg; 2013 Jul; 96(1):259-63: discussion 263-4. PubMed ID: 23673067
[TBL] [Abstract][Full Text] [Related]
60. Malignant pleural effusion treatment outcomes: pleurodesis via video-assisted thoracic surgery (VATS) versus tube thoracostomy.
Luh SP; Chen CY; Tzao CY
Thorac Cardiovasc Surg; 2006 Aug; 54(5):332-6. PubMed ID: 16902882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
